These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24697244)

  • 21. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
    Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
    Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.
    Stukenbrock H; Mussmann R; Geese M; Ferandin Y; Lozach O; Lemcke T; Kegel S; Lomow A; Burk U; Dohrmann C; Meijer L; Austen M; Kunick C
    J Med Chem; 2008 Apr; 51(7):2196-207. PubMed ID: 18345612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel GSK-3 inhibitors with improved cellular activity.
    Peat AJ; Garrido D; Boucheron JA; Schweiker SL; Dickerson SH; Wilson JR; Wang TY; Thomson SA
    Bioorg Med Chem Lett; 2004 May; 14(9):2127-30. PubMed ID: 15080993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
    Koeberle A; Muñoz E; Appendino GB; Minassi A; Pace S; Rossi A; Weinigel C; Barz D; Sautebin L; Caprioglio D; Collado JA; Werz O
    J Med Chem; 2014 Jul; 57(13):5638-48. PubMed ID: 24920381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy.
    Gürses T; Olğaç A; Garscha U; Gür Maz T; Bal NB; Uludağ O; Çalışkan B; Schubert US; Werz O; Banoglu E
    Bioorg Chem; 2021 Jul; 112():104861. PubMed ID: 33826984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition.
    Hanke T; Lamers C; Gomez RC; Schneider G; Werz O; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3757-63. PubMed ID: 25037914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors.
    Cho GW; Noh MY; Kang BY; Ku IW; Park J; Hong YH; Kim MH; Kim SH
    Assay Drug Dev Technol; 2011 Oct; 9(5):503-13. PubMed ID: 21561378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.
    Smalley TL; Peat AJ; Boucheron JA; Dickerson S; Garrido D; Preugschat F; Schweiker SL; Thomson SA; Wang TY
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2091-4. PubMed ID: 16460937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.
    Filosa R; Peduto A; Aparoy P; Schaible AM; Luderer S; Krauth V; Petronzi C; Massa A; de Rosa M; Reddanna P; Werz O
    Eur J Med Chem; 2013 Sep; 67():269-79. PubMed ID: 23871907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.
    Peat AJ; Boucheron JA; Dickerson SH; Garrido D; Mills W; Peckham J; Preugschat F; Smalley T; Schweiker SL; Wilson JR; Wang TY; Zhou HQ; Thomson SA
    Bioorg Med Chem Lett; 2004 May; 14(9):2121-5. PubMed ID: 15080992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of GSK-3 activity, enzymatic inhibition and gene silencing by RNAi on tick oviposition and egg hatching.
    Fabres A; De Andrade CP; Guizzo M; Sorgine MH; Paiva-Silva Gde O; Masuda A; Vaz Ida S; Logullo C
    Parasitology; 2010 Sep; 137(10):1537-46. PubMed ID: 20500916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.
    Testard A; Logé C; Léger B; Robert JM; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3419-23. PubMed ID: 16644220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
    Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
    Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3.
    Lee S; Yang WK; Song JH; Ra YM; Jeong JH; Choe W; Kang I; Kim SS; Ha J
    Biochem Pharmacol; 2013 Apr; 85(7):965-76. PubMed ID: 23337568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP).
    Banoglu E; Çalişkan B; Luderer S; Eren G; Özkan Y; Altenhofen W; Weinigel C; Barz D; Gerstmeier J; Pergola C; Werz O
    Bioorg Med Chem; 2012 Jun; 20(12):3728-41. PubMed ID: 22607880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds.
    Werstuck GH; Kim AJ; Brenstrum T; Ohnmacht SA; Panna E; Capretta A
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5465-7. PubMed ID: 15482904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mediterranean purple indirubins: a source of GSK-3 inhibitors].
    Meijer L
    Med Sci (Paris); 2004 May; 20(5):516-8. PubMed ID: 15190467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.